Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in PGEN — Precigen, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to PGEN Full portfolio

Position in PGEN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,941,219
+$1,159,624 QoQ
Shares Held
340,565
+68.6% QoQ
Ownership
0.095%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 210 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 97% Shared 0% None 3%

Common Shares in PGEN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. PGEN ranks #104 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in PGEN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,941,219 340,565
2026-03-31 $781,595 201,963
2025-12-31 $1,364,150 326,352
2025-09-30 $637,798 193,860
2025-06-30 $228,092 160,629
2025-03-31 $218,218 146,456
2024-12-31 $128,304 114,558
2024-09-30 $97,158 102,273
2024-06-30 $165,178 104,544
2024-03-31 $140,983 97,231
2023-12-31 $132,108 98,589
2023-09-30 $128,599 90,564
2023-06-30 $120,682 104,942
2023-03-31 $78,719 74,265
2022-12-31 $93,991 61,837
2022-09-30 $316,527 149,306
2022-06-30 $200,587 149,693
2022-03-31 $236,882 112,267
2021-12-31 $613,457 165,353
2021-09-30 $2,404,065 481,777
2021-06-30 $2,553,406 391,627
2021-03-31 $2,435,634 353,503
2020-12-31 $2,416,705 236,932
2020-09-30 $785,360 224,389
2020-06-30 $1,338,480 268,233
2020-03-31 $543,815 159,946